What new treatments for Parkinson’s disease are being developed in Europe?

January 21, 2025

The Parkinson’s Protocol™ By Jodi Knapp Parkinson’s disease cannot be eliminated completely but its symptoms can be reduced, damages can be repaired and its progression can be delayed considerably by using various simple and natural things. In this eBook, a natural program to treat Parkinson’s disease is provided online. it includes 12 easy steps to repair your body and reduce the symptoms of this disease. The creator of this program has divided into four segments to cover a complete plan to treat this disease along with improving your health and life by knowing everything about this health problem. The main focus of this program is on boosting the levels of hormone in your brain by making e a few easy changes in your lifestyle, diet, and thoughts


What new treatments for Parkinson’s disease are being developed in Europe?

Several innovative treatments for Parkinson’s disease are currently being developed across Europe. These advancements include:

  1. RNA-Based Therapies: The PARMED consortium, a collaboration involving Neumirna Therapeutics, Motac Neuroscience, and the University of Bordeaux, is focusing on developing RNA therapies aimed at modifying the disease’s progression and improving patients’ quality of life.
  2. Stem Cell Transplants: In Sweden, researchers at Lund University have initiated clinical trials using pluripotent stem cell-derived dopamine neurons to treat Parkinson’s disease. These trials represent Europe’s first steps toward regenerative treatments for the disease.
  3. Advanced Drug Therapies: AbbVie has introduced PRODUODOPA® in the EU, a 24-hour subcutaneous infusion therapy designed to provide continuous levodopa delivery. This treatment aims to reduce motor fluctuations in advanced Parkinson’s patients.
  4. Genetic Testing Initiatives: In Germany, Centogene has emphasized the significance of genetic testing for Parkinson’s patients. This initiative aims to improve participation in clinical trials and advance the development of targeted treatments based on genetic profiles.
  5. Graphene-Based Brain Implants: A clinical trial in the UK is set to explore a graphene-based brain implant developed at the National Graphene Institute in Manchester. This implant could significantly improve brain-computer interfaces and hold potential for treating neurological conditions like Parkinson’s disease.

These developments reflect the significant ongoing efforts in Europe to enhance Parkinson’s disease treatments through a variety of cutting-edge approaches.

In Asia, several new treatments for Parkinson’s disease are being actively developed, focusing on innovative drug therapies, medical technologies, and disease-modifying approaches:

  1. Continuous Subcutaneous Levodopa Infusion: Following successful trials in Europe, the continuous subcutaneous infusion of levodopa (similar to insulin pumps) is being explored for Parkinson’s patients in Asia. This method helps to maintain consistent medication levels, reducing motor fluctuations in advanced stages of the disease.
  2. Safinamide as Adjunct Therapy: Safinamide, a medication used to manage motor fluctuations, has been studied extensively in Asia. Clinical research indicates that it can effectively reduce symptoms when added to existing levodopa therapy, enhancing overall treatment outcomes for patients in the region.
  3. Prasinezumab (Monoclonal Antibody): This disease-modifying therapy, targeting the protein α-synuclein associated with Parkinson’s, is undergoing clinical trials in various Asian countries. It has shown potential to slow disease progression in early-stage patients and is viewed as a promising breakthrough in modifying the course of Parkinson’s.
  4. Zonisamide as an Adjunct to Levodopa: Zonisamide, a drug already approved in Japan, is used alongside levodopa to improve motor symptoms. Its effectiveness in combination therapy has made it a key treatment option in Japan and other parts of Asia for enhancing levodopa’s efficacy in managing Parkinson’s symptoms.
  5. Stem Cell Therapies: Research is ongoing in countries like Japan and South Korea, where stem cell therapies are being tested for their potential to regenerate dopaminergic neurons in the brain, offering a path toward potentially disease-modifying treatments.

These advancements indicate that Asian researchers and healthcare providers are actively contributing to the global effort to improve Parkinson’s disease treatments, focusing on both symptomatic management and modifying the disease’s progression.


The Parkinson’s Protocol™ By Jodi Knapp Parkinson’s disease cannot be eliminated completely but its symptoms can be reduced, damages can be repaired and its progression can be delayed considerably by using various simple and natural things. In this eBook, a natural program to treat Parkinson’s disease is provided online. it includes 12 easy steps to repair your body and reduce the symptoms of this disease. The creator of this program has divided into four segments to cover a complete plan to treat this disease along with improving your health and life by knowing everything about this health problem. The main focus of this program is on boosting the levels of hormone in your brain by making e a few easy changes in your lifestyle, diet, and thoughts